Ursodeoxycholate alleviates alcoholic fatty liver damage in rats

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 7, 1998, Pages 1538-1543

  Oliva, L ^a   Beauge F ^b   Choquart, D ^b   Montet, A M ^a   Guitaoui, M ^a   Montet, J C ^a  

^a INSERM   (France)

^b Pernod Ricard   (France)

Author keywords

Ethanol; Liver; Membrane Fluidity; Steatosis; Ursodeoxycholate

Indexed keywords

URSODEOXYCHOLIC ACID;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DRUG EFFECT; LIPID PEROXIDATION; LIVER FATTY DEGENERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEATOSIS;

EID: 0031725532     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb03947.x     Document Type: Article

References (35)

1. Teli MR, Day CP, Burt AD, Bennett MK, James OF: Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346:987-990, 1995
2. Yamada S, Lieber CS: Decrease in microviscosity and cholesterol content of rat liver plasma membranes after chronic ethanol feeding. J Clin Invest 74:2285-2289, 1984
3. Yamada S, Mak K, Lieber CS: Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology 88:1799-1806, 1985
4. Beaugé F, Stibler H, Borg S: Abnormal fluidity and surface carbohydrate contents of the erythrocyte membrane in alcoholic patients. Alcohol Clin Exp Res 9:322-326, 1985
5. Carey MC, Montet JC, Philips MC, Armstrong MJ, Mazer NA: Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: Cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates. Biochemistry 20:3637-3648, 1981
6. Leuschner U, Fischer H, Kurtz W, Güldütuna S, Hübner K, Hellstern A, Gatzen M, Leuschner M: Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial. Gastroenterology 97:1268-1274, 1989
7. Poupon RE, Balkau B, Eschwège E, Poupon R, and the UDCA-PBC Study Group: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324:1548-1554, 1991
8. Beuers U, Splengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial. Hepatology 16:707-714, 1992
9. Galabert C, Montet JC, Lengrand D, Lecuire A, Sotta C, Figarella C, Chazalette JP: Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis. J Pediatr 121:138-141, 1992
10. Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KDR: Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: A dose-response study. Hepatology 16:924-930, 1992
11. Queneau PE, Bertault-Peres P, Guitaoui M, Mesdjian E, Durand A, Montet JC: Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat. Dig Dis Sci 39: 1581-1585, 1994
12. Zhao XM, Montet JC: Effects of bile salt supplementation on biliary secretion in estrogen-treated rats. J Nutr Biochem 1:420-425, 1990
13. Mesdjian E, Zamora AJ, Montet AM, Bonneton J, Guitaoui M, Genton P, Montet JC: Ursodeoxycholate improves hepatobiliary dysfunction induced by valproate-carbamazepine treatment in the rat. Life Sci 59:1069-1079, 1996
14. Güldütuna S, Zimmer G, Imhof M, Bhatti S, You T, Leuschner U: Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 104:1736-1744, 1993
15. Güldütuna S, Deisinger B, Weiss A, Freisleben HJ, Zimmer G, Sipos P, Leuschner U: Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: Investigations on large unilamellar vesicles. Biochim Biophys Acta 1326:265-274, 1997
16. Heuman DM, Pandak WM, Hylemon PB, Vlahcevic ZR: Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes. Hepatology 14:920-926, 1991
17. Plevris JN, Hayes PC, Bouchier IA: Ursodeoxycholic acid in the treatment of alcoholic liver disease. Eur J Gastroenterol Hepatol 3:653-656, 1991
18. Lieber CS, DeCarli LM: Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol 24:197-211, 1989
19. Turley SD, Dietschy JM: Reevaluation of the 3α-hydroxysteroid dehydrogenase assay for total bile acids. J Lipid Res 19:924-928, 1978
20. Loten EG, Redshaw-Loten JC: Preparation of rat liver plasma membranes in a high yield. Anal Biochem 154:183-185, 1986
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 192:265-275, 1951
22. Choquart D, Kerfriden G, Beaugé FJ: Acute and chronic membrane toxicity of ethanol, liver plasma membrane and nuclear envelope. Alcohol Alcohol 30:504, 1995
23. Zérouga M, Beaugé F, Niel E, Durand G, Bourre JM: Interactive effects of dietary (n-3) polyunsaturated fatty acids and chronic ethanol intoxication on synaptic membrane lipid composition and fluidity in rats. Biochim Biophys Acta 1086:295-304, 1991
24. Beaugé F, Zérouga M, Durand G, Bourre JM: Influence of dietary n-6/n-3 polyunsaturated fatty acid balance on the development of tolerance during chronic ethanol intoxication in rats. Alcohol Alcohol 27:257-265, 1992
25. Shinitzky M, Inbar M: Microviscosity parameters and protein mobility in biological membranes. Biochim Biophys Acta 433:133-149, 1976
26. Leguicher A, Beaugé F, Nordmann R: Concomitant changes of ethanol partitioning and disordering capacities in rat synaptic membranes. Biochem Pharmacol 36:2045-2048, 1987
27. Lieber CS: Alcohol and the liver: 1994 update. Gastroenterology 106:1085-1105, 1994
28. Alvaro D, Benedetti A, Gigliozzi A, Bini A, Della Guardia P, La Rosa T, Jezequel AM, Capocaccia L: Functional and ultrastructural features of ethanol/bile salts interaction in the isolated perfused rat liver. Hepatology 21:1120-1129, 1995
29. Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR: Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 100:203-211, 1991
30. Zhao XM, Montet AM, Montet JC: β-Muricholic acid: A new hepatoprotective agent. J Nutr Biochem 4:105-112, 1993
31. Neuman MG, Cameron RG, Shear NH, Bellentani S, Tiribelli C: Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line. Gastroenterology 109:555-563, 1995
32. Lettéron P, Fromenty B, Terris B, Degott C, Pessayre D: Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 24:200-208, 1996
33. Polokoff MA, Simon TJ, Harris RA, Simon FR, Iwahashi M: Chronic ethanol increases liver plasma membrane fluidity. Biochemistry 24:3114-3120, 1985
34. Kim CI, Leo MA, Lowe N, Lieber CS: Differential effects of retinoids and chronic ethanol consumption on membranes in rats. J Nutr 118:1097-1103, 1988
35. Choquart D, Beaugé F: Acute and chronic membrane toxicity of ethanol. A fluorescence polarization study. Toxicol Lett 78:25, 1995